rs761533681

Variant summary

Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM5PP3PP5_Very_Strong

The NM_003038.5(SLC1A4):​c.1369C>T​(p.Arg457Trp) variant causes a missense change. The variant allele was found at a frequency of 0.0000248 in 1,611,924 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R457Q) has been classified as Likely pathogenic.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000026 ( 0 hom. )

Consequence

SLC1A4
NM_003038.5 missense

Scores

12
6
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:10

Conservation

PhyloP100: 5.95

Publications

11 publications found
Variant links:
Genes affected
SLC1A4 (HGNC:10942): (solute carrier family 1 member 4) The protein encoded by this gene is a sodium-dependent neutral amino acid transporter for alanine, serine, cysteine, and threonine. Defects in this gene have been associated with developmental delay, microcephaly, and intellectual disability. [provided by RefSeq, Jan 2017]
LINC02245 (HGNC:53134): (long intergenic non-protein coding RNA 2245)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 11 ACMG points.

PM5
Other missense variant is known to change same aminoacid residue: Variant chr2-65020917-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 1685441.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.801
PP5
Variant 2-65020916-C-T is Pathogenic according to our data. Variant chr2-65020916-C-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 372158.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC1A4NM_003038.5 linkc.1369C>T p.Arg457Trp missense_variant Exon 8 of 8 ENST00000234256.4 NP_003029.2
SLC1A4NM_001348406.2 linkc.709C>T p.Arg237Trp missense_variant Exon 8 of 8 NP_001335335.1
SLC1A4NM_001348407.2 linkc.709C>T p.Arg237Trp missense_variant Exon 8 of 8 NP_001335336.1
SLC1A4NM_001193493.2 linkc.475C>T p.Arg159Trp missense_variant Exon 7 of 7 NP_001180422.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC1A4ENST00000234256.4 linkc.1369C>T p.Arg457Trp missense_variant Exon 8 of 8 1 NM_003038.5 ENSP00000234256.3 P43007-1

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152170
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000123
AC:
31
AN:
251166
AF XY:
0.0000810
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.000781
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000490
GnomAD4 exome
AF:
0.0000260
AC:
38
AN:
1459754
Hom.:
0
Cov.:
30
AF XY:
0.0000262
AC XY:
19
AN XY:
726322
show subpopulations
African (AFR)
AF:
0.0000897
AC:
3
AN:
33446
American (AMR)
AF:
0.000693
AC:
31
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86222
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000270
AC:
3
AN:
1110066
Other (OTH)
AF:
0.0000166
AC:
1
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152170
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74344
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41418
American (AMR)
AF:
0.0000654
AC:
1
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5202
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68028
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000533
Hom.:
0
Bravo
AF:
0.0000264
ExAC
AF:
0.000157
AC:
19

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome Pathogenic:6
-
Lupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:research

This variant was identified in an individual with developmental delay, microcephaly, corpus callosum agenesis, hypomyelination. -

Apr 17, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 03, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: SLC1A4 c.1369C>T (p.Arg457Trp) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 251166 control chromosomes (gnomAD). c.1369C>T has been reported in the literature in the homozygous state in two unrelated individuals affected with Spastic Tetraplegia-Thin Corpus Callosum-Progressive Postnatal Microcephaly Syndrome (Damseh_2015, Eldomery_2017). These data indicate that the variant is likely to be associated with disease. A functional study found that although the variant protein is expressed at a similar level as the WT protein at the plasma membrane, it has no detectable transport activity (Damseh_2015). The following publications have been ascertained in the context of this evaluation (PMID: 26041762, 28327206). Five submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n=4)/likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -

Jun 15, 2020
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Feb 16, 2023
Revvity Omics, Revvity
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 30, 2023
3billion
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.012%). Predicted Consequence/Location: Missense variant In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.76; 3Cnet: 0.93). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000372158 /PMID: 26041762). A different missense change at the same codon (p.Arg457Gln) has been reported to be associated with SLC1A4 related disorder (ClinVar ID: VCV001685441). However the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -

not provided Pathogenic:3
Dec 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SLC1A4: PM2, PM3, PP3, PS4:Supporting -

Sep 10, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Published functional studies demonstrate p.R457W impairs transporter activity (PMID: 26041762); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 31763347, 26041762, Stehantsev2021[article], 33310157, 34174466, 37194416, 28327206, 2837306) -

Dec 09, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 457 of the SLC1A4 protein (p.Arg457Trp). This variant is present in population databases (rs761533681, gnomAD 0.05%). This missense change has been observed in individuals with cerebral palsy and/or spastic tetraplegia, thin corpus callosum, and progressive microcephaly (PMID: 2837306, 26041762, 33528536; internal data). ClinVar contains an entry for this variant (Variation ID: 372158). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC1A4 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects SLC1A4 function (PMID: 26041762). This variant disrupts the p.Arg457 amino acid residue in SLC1A4. Other variant(s) that disrupt this residue have been observed in individuals with SLC1A4-related conditions (PMID: 26041762, 34174466), which suggests that this may be a clinically significant amino acid residue. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -

Inborn genetic diseases Pathogenic:1
May 04, 2017
Ambry Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.87
BayesDel_addAF
Uncertain
0.13
D
BayesDel_noAF
Pathogenic
0.28
CADD
Pathogenic
29
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.77
.;D
Eigen
Pathogenic
0.77
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Pathogenic
0.98
D;D
M_CAP
Pathogenic
0.35
D
MetaRNN
Pathogenic
0.80
D;D
MetaSVM
Uncertain
0.30
D
MutationAssessor
Pathogenic
4.4
.;H
PhyloP100
5.9
PrimateAI
Pathogenic
0.86
D
PROVEAN
Pathogenic
-7.4
D;D
REVEL
Pathogenic
0.76
Sift
Pathogenic
0.0
D;D
Sift4G
Uncertain
0.0020
D;D
Polyphen
1.0
.;D
Vest4
0.95
MutPred
0.69
.;Gain of sheet (P = 0.0085);
MVP
0.90
MPC
1.1
ClinPred
0.99
D
GERP RS
4.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.96
gMVP
0.98
Mutation Taster
=8/92
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs761533681; hg19: chr2-65248050; COSMIC: COSV52235153; COSMIC: COSV52235153; API